NEETPGAI
FeaturesBlogComparePricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Features
  • Subjects
  • Previous Year Questions
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Contact & support

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Pediatrics/CSWS — Continuous Spike-and-Wave during Slow Sleep
    CSWS — Continuous Spike-and-Wave during Slow Sleep
    medium
    smile Pediatrics

    A 6-year-old boy presents with a 3-month history of focal motor seizures and progressive decline in school performance, attention, and language. His parents report he is becoming withdrawn and less interactive. Routine awake EEG shows only mild focal slowing. An overnight sleep-deprived EEG is obtained, and the pattern marked **A** in the diagram is observed, occupying >85% of his NREM sleep with marked normalization upon awakening. Which of the following is the MOST appropriate first-line therapeutic approach for this condition?

    A. High-dose benzodiazepines (clobazam) combined with oral corticosteroids (prednisolone)
    B. Phenytoin loading followed by maintenance therapy
    C. Oxcarbazepine with lamotrigine as adjunctive agent
    D. Carbamazepine monotherapy with gradual dose escalation

    Explanation

    Why High-dose benzodiazepines (clobazam) combined with oral corticosteroids (prednisolone) is right

    The pattern marked A — continuous bilateral spike-and-wave during NREM sleep occupying >85% of sleep — is the defining EEG hallmark of Continuous Spike-and-Wave during Slow Sleep (CSWS), also called Electrical Status Epilepticus during Sleep (ESES). This is a rare age-dependent epileptic encephalopathy with peak onset 4–8 years, characterized by heterogeneous seizures, neurocognitive regression (global, language, attention, behaviour), and the near-continuous spike-and-wave pattern that normalizes upon awakening. The clinical anchor is that CSWS is defined by this specific EEG pattern combined with cognitive plateau or regression. First-line therapy is high-dose benzodiazepines (clobazam or short pulses of diazepam) and corticosteroids (oral prednisolone, IV methylprednisolone pulses, or ACTH). Early aggressive treatment is essential because untreated cognitive deficits may persist into adulthood even after EEG normalization. [ILAE Classification 2017 — Childhood Epileptic Encephalopathies; Tassinari]

    Why each distractor is wrong

    • Carbamazepine monotherapy with gradual dose escalation: Carbamazepine is explicitly contraindicated in CSWS and may aggravate spike-and-wave activity. It is one of the drugs to be avoided in this condition.
    • Phenytoin loading followed by maintenance therapy: Phenytoin is also contraindicated in CSWS as it can worsen the spike-and-wave pattern and cognitive decline. It should be avoided.
    • Oxcarbazepine with lamotrigine as adjunctive agent: Oxcarbazepine, like carbamazepine, is a sodium channel blocker that may aggravate CSWS and should be avoided. Lamotrigine alone is not first-line therapy for this condition.
    High-YieldNEET PG
    CSWS is defined by >85% spike-wave index during NREM sleep + cognitive regression; first-line therapy is high-dose benzodiazepines + corticosteroids; avoid carbamazepine, oxcarbazepine, phenytoin, and phenobarbital as they may worsen the EEG pattern and cognitive outcome.

    ILAE Classification 2017 — Childhood Epileptic Encephalopathies; Tassinari

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Pediatrics Questions